WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Fluvoxamine Maleate in Pennsylvania

Find doctors, physicians, and healthcare providers who prescribe Fluvoxamine Maleate in Pennsylvania. This page lists the top prescribers of Fluvoxamine Maleate based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Fluvoxamine Maleate?

Fluvoxamine maleate extended-release capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of obsessive compulsive disorder (OCD) ( 1 ). effectiveness was demonstrated in: One 12-week study fluvoxamine maleate extended-release capsules in adults ( 14.1 ).

Total Claims in Pennsylvania
20,054
7.1% of all Fluvoxamine Maleate prescriptions nationwide
Total Beneficiaries in Pennsylvania
294
Total Cost in Pennsylvania
$967,503

Top Prescribers in PA(5+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
David KalksteinPhiladelphia, PAPsychiatry30260$18,066
Ann Marie Wolf-SchatzNorristown, PAPsychiatry29022$13,212
Robert HudakPittsburgh, PAPsychiatry20321$11,660
Kenneth RosensteinPhiladelphia, PAPsychiatry14312$7,794
Andrew SolowayChester, PAPsychiatry14314$9,430
Loading more data in background...

Find Fluvoxamine Maleate doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.